Innovent

Top 10 most anticipated drug launches of 2025

According to Evaluate’s forecasts, the biggest potential drug launches of the coming year stand to generate $29 billion in total annual sales by 2030.

Andrea Park , Nick Paul Taylor Jan 27, 2025 3:00am

Pfizer, Astellas, Takeda, Innovent and more—Fierce Pharma Asia

Jan 12, 2024 8:15am

Takeda, Hutchmed hook up on cancer drug for $1.13B

Jan 23, 2023 10:31am

Coherus and Junshi's cancer immunotherapy has stalled at the FDA

May 3, 2022 8:02am

FDA oncology chief, Senate bill, Insilico—Fierce Pharma Asia

Apr 1, 2022 9:35am

FDA oncology czar defends rejection of Lilly-Innovent PD-1

Mar 28, 2022 11:34am